References
Adam E, Hansen KK, Astudillo Fernandez O, Coulon L, Bex F, Duhant X, et al. (2006). The house dust mite allergen Der p 1, unlike Der p 3, stimulates the expression of interleukin-8 in human airway epithelial cells via a proteinase-activated receptor-2-independent mechanism. J Biol Chem 281: 6910-6923.
Adams MN, Ramachandran R, Yau MK, Suen JY, Fairlie DP, Hollenberg MD, et al. (2011). Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther 130: 248-282.
Addison KJ, Morse J, Robichaud A, Daines MO, & Ledford JG (2017). A Novel in vivo System to Test Bronchodilators. J Infect Pulm Dis 3.
Aikawa T, Shimura S, Sasaki H, Ebina M, & Takishima T (1992). Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 101:916-921.
Andersson C, Tufvesson E, Diamant Z, & Bjermer L (2016). Revisiting the role of the mast cell in asthma. Curr Opin Pulm Med 22: 10-17.
Arizmendi NG, Abel M, Mihara K, Davidson C, Polley D, Nadeem A, et al. (2011). Mucosal allergic sensitization to cockroach allergens is dependent on proteinase activity and proteinase-activated receptor-2 activation. J Immunol 186: 3164-3172.
Asaduzzaman M, Davidson C, Nahirney D, Fiteih Y, Puttagunta L, & Vliagoftis H (2018). Proteinase-activated receptor-2 blockade inhibits changes seen in a chronic murine asthma model. Allergy 73:416-420.
Asaduzzaman M, Nadeem A, Arizmendi N, Davidson C, Nichols HL, Abel M, et al. (2015). Functional inhibition of PAR2 alleviates allergen-induced airway hyperresponsiveness and inflammation. Clin Exp Allergy 45: 1844-1855.
Avet C, Sturino C, Grastilleur S, Gouill CL, Semache M, Gross F, et al. (2020). The PAR2 inhibitor I-287 selectively targets Galphaq and Galpha12/13 signaling and has anti-inflammatory effects. Commun Biol 3: 719.
Batra M, Vicendese D, Newbigin E, Lambert KA, Tang M, Abramson MJ, et al. (2021). The association between outdoor allergens - pollen, fungal spore season and high asthma admission days in children and adolescents. Int J Environ Health Res: 1-10.
Boitano S, Flynn AN, Sherwood CL, Schulz SM, Hoffman J, Gruzinova I, et al. (2011). Alternaria alternata serine proteases induce lung inflammation and airway epithelial cell activation via PAR2. Am J Physiol Lung Cell Mol Physiol 300: L605-614.
Boitano S, Hoffman J, Flynn AN, Asiedu MN, Tillu DV, Zhang Z, et al. (2015). The novel PAR2 ligand C391 blocks multiple PAR2 signaling pathways in vitro and in vivo. British journal of pharmacology 172: 4535-4545.
Bush RK, & Prochnau JJ (2004). Alternaria-induced asthma. J Allergy Clin Immunol 113: 227-234.
Cheng RKY, Fiez-Vandal C, Schlenker O, Edman K, Aggeler B, Brown DG, et al. (2017). Structural insight into allosteric modulation of protease-activated receptor 2. Nature 545: 112-115.
Chiu LL, Perng DW, Yu CH, Su SN, & Chow LP (2007). Mold allergen, pen C 13, induces IL-8 expression in human airway epithelial cells by activating protease-activated receptor 1 and 2. J Immunol 178:5237-5244.
Chow JM, Moffatt JD, & Cocks TM (2000). Effect of protease-activated receptor (PAR)-1, -2 and -4-activating peptides, thrombin and trypsin in rat isolated airways. Br J Pharmacol 131: 1584-1591.
Chung KF (2018). Tralokinumab unsuccessful for management of severe, uncontrolled asthma. Lancet Respir Med 6: 480-481.
Cocks TM, Fong B, Chow JM, Anderson GP, Frauman AG, Goldie RG, et al. (1999). A protective role for protease-activated receptors in the airways. Nature 398: 156-160.
Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin KE, Finkbeiner WE, et al. (1994). CFTR expression and chloride secretion in polarized immortal human bronchail epithelial cells. Am J Respir Cell Mol Biol 10: 38 - 47.
Curtis MJ, Alexander S, Cirino G, Docherty JR, George CH, Giembycz MA, et al. (2018). Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. Br J Pharmacol 175: 987-993.
Davidson CE, Asaduzzaman M, Arizmendi NG, Polley D, Wu Y, Gordon JR, et al. (2013). Proteinase-activated receptor-2 activation participates in allergic sensitization to house dust mite allergens in a murine model. Clin Exp Allergy 43: 1274-1285.
Day SB, Zhou P, Ledford JR, & Page K (2010). German cockroach frass proteases modulate the innate immune response via activation of protease-activated receptor-2. J Innate Immun 2: 495-504.
Ebeling C, Forsythe P, Ng J, Gordon JR, Hollenberg M, & Vliagoftis H (2005). Proteinase-activated receptor 2 activation in the airways enhances antigen-mediated airway inflammation and airway hyperresponsiveness through different pathways. J Allergy Clin Immunol 115: 623-630.
Flynn AN, Tillu DV, Asiedu MN, Hoffman J, Vagner J, Price TJ, et al. (2011). The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH2 and 6-aminonicotinyl-LIGRL-NH2 stimulate multiple signaling pathways to induce physiological responses in vitro and in vivo. The Journal of Biological Chemistry 286: 19076-19088.
Forbes B, Shah A, Martin GP, & Lansley AB (2003). The human bronchial epithelial cell line 16HBE14o- as a model system of the airways for studying drug transport. Int J Pharm 257: 161-167.
Gardell LR, Ma JN, Seitzberg JG, Knapp AE, Schiffer HH, Tabatabaei A, et al. (2008). Identification and characterization of novel small-molecule protease-activated receptor 2 agonists. J Pharmacol Exp Ther 327: 799-808.
Ge L, Ly Y, Hollenberg M, & DeFea K (2003). A β-Arrestin-dependent Scaffold Is Associated with Prolonged MAPK Activation in Pseudopodia during Protease-activated Receptor-2-induced Chemotaxis *. Journal of Biological Chemistry 278: 34418-34426.
Goh FG, Ng PY, Nilsson M, Kanke T, & Plevin R (2009). Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling. British journal of pharmacology 158: 1695-1704.
Gruenert DC, Finkbeiner WE, & Widdicombe JH (1995). Culture and transformation of human airway epithelial cells. Am J Physiol 268: L347-360.
Grynkiewicz G, Poenie M, & Tsien RY (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
Halonen M, Stern DA, Wright AL, Taussig LM, & Martinez FD (1997). Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 155: 1356-1361.
Hanania NA, Korenblat P, Chapman KR, Bateman ED, Kopecky P, Paggiaro P, et al. (2016). Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med 4: 781-796.
Henry PJ (2006). The protease-activated receptor2 (PAR2)-prostaglandin E2-prostanoid EP receptor axis: a potential bronchoprotective unit in the respiratory tract? Eur J Pharmacol 533: 156-170.
Hoffman J, Flynn A, Tillu D, Zhang Z, Patek R, Price T, et al.(2012). Lanthanide labeling of a potent protease activated receptor-2 agonist for time-resolved fluorescence analysis. Bioconjug Chem 23: 2098-2104.
Hollenberg MD, Mihara K, Polley D, Suen JY, Han A, Fairlie DP, et al. (2014). Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease. British journal of pharmacology 171: 1180-1194.
Hollenberg MD, Saifeddine M, & al-Ani B (1996). Proteinase-activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides. Mol Pharmacol 49: 229-233.
Huang X, Ni B, Xi Y, Chu X, Zhang R, & You H (2019). Protease-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritis. Aging (Albany NY) 11: 12532-12545.
Jairaman A, Yamashita M, Schleimer RP, & Prakriya M (2015). Store-Operated Ca2+ Release-Activated Ca2+ Channels Regulate PAR2-Activated Ca2+ Signaling and Cytokine Production in Airway Epithelial Cells. J Immunol.
Jiang Y, Yau MK, Lim J, Wu KC, Xu W, Suen JY, et al. (2018). A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells. J Pharmacol Exp Ther 364: 246-257.
Jimenez-Vargas NN, Pattison LA, Zhao P, Lieu T, Latorre R, Jensen DD, et al. (2018). Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome. Proc Natl Acad Sci U S A.
Kabashima K, Nakashima C, Nonomura Y, Otsuka A, Cardamone C, Parente R, et al. (2018). Biomarkers for evaluation of mast cell and basophil activation. Immunol Rev 282: 114-120.
Kanke T, Ishiwata H, Kabeya M, Saka M, Doi T, Hattori Y, et al.(2005). Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2. British journal of pharmacology 145: 255-263.
Kennedy AJ, Sundström L, Geschwindner S, Poon EKY, Jiang Y, Chen R, et al. (2020). Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition. Communications Biology 3: 782.
Knight DA, Lim S, Scaffidi AK, Roche N, Chung KF, Stewart GA, et al. (2001). Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J Allergy Clin Immunol 108: 797-803.
Ledford JG, Addison KJ, Francisco D, Foster MW, Voelker DR, Que LG, et al. (2016). Genetic Variation in Surfactant Protein-A2 Results in Altered Regulation of Eosinophil Activities and Enhanced Eosinophilia in Patients with Asthma. Ann Am Thorac Soc 13 Suppl 1: S101.
Lombardi C, Savi E, Ridolo E, Passalacqua G, & Canonica GW (2017). Is allergic sensitization relevant in severe asthma? Which allergens may be culprit? World Allergy Organ J 10: 2.
Martinez FD, & Vercelli D (2013). Asthma. Lancet 382:1360-1372.
McGuire JJ, Saifeddine M, Triggle CR, Sun K, & Hollenberg MD (2004). 2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist. J Pharmacol Exp Ther 309: 1124-1131.
Mendy A, Wilkerson J, Salo PM, Zeldin DC, & Thorne PS (2020). Endotoxin clustering with allergens in house dust and asthma outcomes in a U.S. national study. Environ Health 19: 35.
Nichols HL, Saffeddine M, Theriot BS, Hegde A, Polley D, El-Mays T, et al. (2012). beta-Arrestin-2 mediates the proinflammatory effects of proteinase-activated receptor-2 in the airway. Proc Natl Acad Sci U S A 109: 16660-16665.
O’Grady SM, Patil N, Melkamu T, Maniak PJ, Lancto C, & Kita H (2013). ATP release and Ca2+ signalling by human bronchial epithelial cells following Alternaria aeroallergen exposure. J Physiol 591:4595-4609.
Ock MS, Kim BJ, Kim SM, & Byun KH (2005). Cloning and expression of trypsin-encoding cDNA from Blattella germanica and its possibility as an allergen. Korean J Parasitol 43: 101-110.
Ogawa H, Azuma M, Tsunematsu T, Morimoto Y, Kondo M, Tezuka T, et al. (2018). Neutrophils induce smooth muscle hyperplasia via neutrophil elastase-induced FGF-2 in a mouse model of asthma with mixed inflammation. Clin Exp Allergy 48: 1715-1725.
Page K, Ledford JR, Zhou P, Dienger K, & Wills-Karp M (2010). Mucosal sensitization to German cockroach involves protease-activated receptor-2. Respir Res 11: 62.
Pera T, & Penn RB (2016). Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones. Pharmacol Ther 164: 82-96.
Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, & Weiss ST (2007). Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 119: 1454-1461.
Polley DJ, Mihara K, Ramachandran R, Vliagoftis H, Renaux B, Saifeddine M, et al. (2017). Cockroach allergen serine proteinases: Isolation, sequencing and signalling via proteinase-activated receptor-2. Clin Exp Allergy 47: 946-960.
Pulimood TB, Corden JM, Bryden C, Sharples L, & Nasser SM (2007). Epidemic asthma and the role of the fungal mold Alternaria alternata. J Allergy Clin Immunol 120: 610-617.
Ramachandran R, & Hollenberg MD (2008). Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 153 Suppl 1: S263-282.
Ramachandran R, Noorbakhsh F, Defea K, & Hollenberg MD (2012). Targeting proteinase-activated receptors: therapeutic potential and challenges. Nat Rev Drug Discov 11: 69-86.
Rayees S, Joshi JC, Tauseef M, Anwar M, Baweja S, Rochford I, et al. (2019). PAR2-Mediated cAMP Generation Suppresses TRPV4-Dependent Ca(2+) Signaling in Alveolar Macrophages to Resolve TLR4-Induced Inflammation. Cell Rep 27: 793-805.e794.
Shrestha Palikhe N, Nahirney D, Laratta C, Gandhi VD, Vethanayagam D, Bhutani M, et al. (2015). Increased Protease-Activated Receptor-2 (PAR-2) Expression on CD14++CD16+ Peripheral Blood Monocytes of Patients with Severe Asthma. PLoS One 10: e0144500.
Snelgrove RJ, Gregory LG, Peiro T, Akthar S, Campbell GA, Walker SA, et al. (2014). Alternaria-derived serine protease activity drives IL-33 mediated asthma exacerbations. J Allergy Clin Immunol: 583-592.
Stephenson KE, Neubauer GH, Bricault CA, Shields J, Bayne M, Reimer U, et al. (2016). Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy. Open Forum Infect Dis 3: ofw100.
Stewart GA, Thompson PJ, & Simpson RJ (1989). Protease antigens from house dust mite. Lancet 2: 154-155.
Sudha VT, Arora N, Gaur SN, Pasha S, & Singh BP (2008). Identification of a serine protease as a major allergen (Per a 10) of Periplaneta americana. Allergy 63: 768-776.
Suen JY, Barry GD, Lohman RJ, Halili MA, Cotterell AJ, Le GT, et al. (2012). Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110). British journal of pharmacology 165: 1413-1423.
Suen JY, Cotterell A, Lohman RJ, Lim J, Han A, Yau MK, et al.(2014). Pathway-selective antagonism of proteinase activated receptor 2. British journal of pharmacology 171: 4112-4124.
Sun G, Stacey MA, Schmidt M, Mori L, & Mattoli S (2001). Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells. J Immunol 167: 1014-1021.
To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. (2012). Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 12: 204.
Wardlaw AJ (1999). Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm. J Allergy Clin Immunol 104:917-926.
Yau MK, Lim J, Liu L, & Fairlie DP (2016). Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015). Expert Opin Ther Pat 26: 471-483.
Yau MK, Liu L, & Fairlie DP (2013). Toward Drugs for Protease-Activated Receptor 2 (PAR2). J Med Chem 56: 7447-7497.
Yee MC, Nichols HL, Polley D, Saifeddine M, Pal K, Lee K, et al.(2018). Protease-activated Receptor-2 Signaling through beta-Arrestin-2 Mediates Alternaria Alkaline Serine Protease-induced Airway Inflammation. Am J Physiol Lung Cell Mol Physiol 315:L1042-L1057.
Zeldin DC, Wohlford-Lenane C, Chulada P, Bradbury JA, Scarborough PE, Roggli V, et al. (2001). Airway Inflammation and Responsiveness in Prostaglandin H Synthase–Deficient Mice Exposed to Bacterial Lipopolysaccharide. American Journal of Respiratory Cell and Molecular Biology 25: 457-465.